261 related articles for article (PubMed ID: 2970788)
1. Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.
Glasser SP; West TW
Am J Cardiol; 1988 Sep; 62(9):518-22. PubMed ID: 2970788
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
3. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
4. A double-blind dose-response study of amlodipine in patients with stable angina pectoris.
Cocco G; Alfiero R
Eur Heart J; 1991 Feb; 12(2):169-74. PubMed ID: 1828420
[TBL] [Abstract][Full Text] [Related]
5. [Amlodipine versus nifedipine retard. A randomized double-blind comparative study on long-term efficacy and safety of amlodipine and nifedipine retard in the monotherapy of chronic stable angina pectoris].
Sauerbrey-Wullkopf N; Kupper W
Herz; 2001 Mar; 26(2):149-56. PubMed ID: 11349617
[TBL] [Abstract][Full Text] [Related]
6. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
7. Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.
DiBianco R; Schoomaker FW; Singh JB; Awan NA; Bennett T; Canosa FL; Kawanishi DT; Bamrah VS; Glasser SP; Barry W
Clin Cardiol; 1992 Jul; 15(7):519-24. PubMed ID: 1354085
[TBL] [Abstract][Full Text] [Related]
8. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
[TBL] [Abstract][Full Text] [Related]
9. Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent.
Kinnard DR; Harris M; Hossack KF
J Am Coll Cardiol; 1988 Sep; 12(3):791-6. PubMed ID: 2969930
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
11. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
12. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
[TBL] [Abstract][Full Text] [Related]
13. Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance.
Kinnard DR; Harris M; Hossack KF
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S110-3. PubMed ID: 2467119
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris.
de Buitleir M; Krikler S; Krikler DM
Am J Cardiol; 1986 Jan; 57(1):15-9. PubMed ID: 3079940
[TBL] [Abstract][Full Text] [Related]
15. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of amlodipine for angina pectoris.
Taylor SH
Am J Cardiol; 1994 Jan; 73(3):28A-33A. PubMed ID: 8310973
[TBL] [Abstract][Full Text] [Related]
17. Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial.
Koenig W; Höher M
J Cardiovasc Pharmacol; 1997 Apr; 29(4):520-4. PubMed ID: 9156363
[TBL] [Abstract][Full Text] [Related]
18. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
[TBL] [Abstract][Full Text] [Related]
19. An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectoris.
Bernink PJ; de Weerd P; ten CF; Remme WJ; Barth J; Enthoven R; Haagen FD; Holwerda NJ; Klomps HC
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S53-6. PubMed ID: 16296711
[TBL] [Abstract][Full Text] [Related]
20. Effects of amlodipine and isosorbide dinitrate on exercise-induced and ambulatory ischemia in patients with chronic stable angina pectoris.
Steffensen R; Melchior T; Bech J; Nissen H; Haastrup B; Grande P; Rasmussen V; Hansen JF; Skagen K; Haghfelt T
Cardiovasc Drugs Ther; 1997 Nov; 11(5):629-35. PubMed ID: 9493700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]